{"entity":{"type":"insider","cik":"0001863624","url":"/insider/0001863624","json_url":"/insider/0001863624.json","name":"Cittadine Andrew","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":12,"n_filings":5,"first":"2022-11-16","last":"2024-06-21","span_basis":"filed_date"},"name_variants":[{"name":"Cittadine Andrew","source":"filing","n_filings":5,"first_seen":"2022-11-16","last_seen":"2024-06-21"}],"transactions":[{"id":2532121,"accession":"0001437749-24-021000","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001437749-24-021000","line_url":"/filing/0001437749-24-021000#line-2","is_derivative":false,"issuer_cik":"0001645469","issuer_name":"Monopar Therapeutics","issuer_ticker":"MNPR","issuer_name_source":null,"issuer_url":"/issuer/0001645469","owner_cik":"0001863624","owner_name":"Cittadine Andrew","owner_display_name":"Cittadine Andrew","owner_url":"/insider/0001863624","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20508.0,"shares_display":"20,508","price_per_share":0.7438,"price_display":"0.74","price_state":"stated","total_value":15253.8504,"total_display":"15,253.85","total_whole":"15,254","shares_owned_after":186132.0,"shares_owned_after_display":"186,132","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-20","filed_date":"2024-06-21","scope":"insider"},{"id":2532117,"accession":"0001437749-24-021000","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-24-021000","line_url":"/filing/0001437749-24-021000#line-1","is_derivative":false,"issuer_cik":"0001645469","issuer_name":"Monopar Therapeutics","issuer_ticker":"MNPR","issuer_name_source":null,"issuer_url":"/issuer/0001645469","owner_cik":"0001863624","owner_name":"Cittadine Andrew","owner_display_name":"Cittadine Andrew","owner_url":"/insider/0001863624","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":12000.0,"shares_display":"12,000","price_per_share":0.86,"price_display":"0.86","price_state":"stated","total_value":10320.0,"total_display":"10,320.00","total_whole":"10,320","shares_owned_after":165624.0,"shares_owned_after_display":"165,624","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-18","filed_date":"2024-06-21","scope":"insider"},{"id":2931977,"accession":"0001437749-24-020547","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001437749-24-020547","line_url":"/filing/0001437749-24-020547#line-3","is_derivative":false,"issuer_cik":"0001645469","issuer_name":"Monopar Therapeutics","issuer_ticker":"MNPR","issuer_name_source":null,"issuer_url":"/issuer/0001645469","owner_cik":"0001863624","owner_name":"Cittadine Andrew","owner_display_name":"Cittadine Andrew","owner_url":"/insider/0001863624","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":12000.0,"shares_display":"12,000","price_per_share":0.8999,"price_display":"0.90","price_state":"stated","total_value":10798.8,"total_display":"10,798.80","total_whole":"10,799","shares_owned_after":153624.0,"shares_owned_after_display":"153,624","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-17","filed_date":"2024-06-17","scope":"insider"},{"id":2931972,"accession":"0001437749-24-020547","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001437749-24-020547","line_url":"/filing/0001437749-24-020547#line-2","is_derivative":false,"issuer_cik":"0001645469","issuer_name":"Monopar Therapeutics","issuer_ticker":"MNPR","issuer_name_source":null,"issuer_url":"/issuer/0001645469","owner_cik":"0001863624","owner_name":"Cittadine Andrew","owner_display_name":"Cittadine Andrew","owner_url":"/insider/0001863624","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":12000.0,"shares_display":"12,000","price_per_share":0.9313,"price_display":"0.93","price_state":"stated","total_value":11175.6,"total_display":"11,175.60","total_whole":"11,176","shares_owned_after":141624.0,"shares_owned_after_display":"141,624","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-14","filed_date":"2024-06-17","scope":"insider"},{"id":2931969,"accession":"0001437749-24-020547","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-24-020547","line_url":"/filing/0001437749-24-020547#line-1","is_derivative":false,"issuer_cik":"0001645469","issuer_name":"Monopar Therapeutics","issuer_ticker":"MNPR","issuer_name_source":null,"issuer_url":"/issuer/0001645469","owner_cik":"0001863624","owner_name":"Cittadine Andrew","owner_display_name":"Cittadine Andrew","owner_url":"/insider/0001863624","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":12000.0,"shares_display":"12,000","price_per_share":0.91,"price_display":"0.91","price_state":"stated","total_value":10920.0,"total_display":"10,920.00","total_whole":"10,920","shares_owned_after":129624.0,"shares_owned_after_display":"129,624","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-13","filed_date":"2024-06-17","scope":"insider"},{"id":2103601,"accession":"0001437749-24-019370","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001437749-24-019370","line_url":"/filing/0001437749-24-019370#line-2","is_derivative":false,"issuer_cik":"0001645469","issuer_name":"Monopar Therapeutics","issuer_ticker":"MNPR","issuer_name_source":null,"issuer_url":"/issuer/0001645469","owner_cik":"0001863624","owner_name":"Cittadine Andrew","owner_display_name":"Cittadine Andrew","owner_url":"/insider/0001863624","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":12000.0,"shares_display":"12,000","price_per_share":0.78,"price_display":"0.78","price_state":"stated","total_value":9360.0,"total_display":"9,360.00","total_whole":"9,360","shares_owned_after":117624.0,"shares_owned_after_display":"117,624","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-04","filed_date":"2024-06-05","scope":"insider"},{"id":2103599,"accession":"0001437749-24-019370","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-24-019370","line_url":"/filing/0001437749-24-019370#line-1","is_derivative":false,"issuer_cik":"0001645469","issuer_name":"Monopar Therapeutics","issuer_ticker":"MNPR","issuer_name_source":null,"issuer_url":"/issuer/0001645469","owner_cik":"0001863624","owner_name":"Cittadine Andrew","owner_display_name":"Cittadine Andrew","owner_url":"/insider/0001863624","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":12000.0,"shares_display":"12,000","price_per_share":0.76,"price_display":"0.76","price_state":"stated","total_value":9120.0,"total_display":"9,120.00","total_whole":"9,120","shares_owned_after":105624.0,"shares_owned_after_display":"105,624","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-03","filed_date":"2024-06-05","scope":"insider"},{"id":2371927,"accession":"0001437749-24-018931","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001437749-24-018931","line_url":"/filing/0001437749-24-018931#line-3","is_derivative":false,"issuer_cik":"0001645469","issuer_name":"Monopar Therapeutics","issuer_ticker":"MNPR","issuer_name_source":null,"issuer_url":"/issuer/0001645469","owner_cik":"0001863624","owner_name":"Cittadine Andrew","owner_display_name":"Cittadine Andrew","owner_url":"/insider/0001863624","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":12000.0,"shares_display":"12,000","price_per_share":0.6443,"price_display":"0.64","price_state":"stated","total_value":7731.6,"total_display":"7,731.60","total_whole":"7,732","shares_owned_after":93624.0,"shares_owned_after_display":"93,624","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-31","filed_date":"2024-05-31","scope":"insider"},{"id":2371923,"accession":"0001437749-24-018931","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001437749-24-018931","line_url":"/filing/0001437749-24-018931#line-2","is_derivative":false,"issuer_cik":"0001645469","issuer_name":"Monopar Therapeutics","issuer_ticker":"MNPR","issuer_name_source":null,"issuer_url":"/issuer/0001645469","owner_cik":"0001863624","owner_name":"Cittadine Andrew","owner_display_name":"Cittadine Andrew","owner_url":"/insider/0001863624","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":12000.0,"shares_display":"12,000","price_per_share":0.6397,"price_display":"0.64","price_state":"stated","total_value":7676.4,"total_display":"7,676.40","total_whole":"7,676","shares_owned_after":81624.0,"shares_owned_after_display":"81,624","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-30","filed_date":"2024-05-31","scope":"insider"},{"id":2371922,"accession":"0001437749-24-018931","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-24-018931","line_url":"/filing/0001437749-24-018931#line-1","is_derivative":false,"issuer_cik":"0001645469","issuer_name":"Monopar Therapeutics","issuer_ticker":"MNPR","issuer_name_source":null,"issuer_url":"/issuer/0001645469","owner_cik":"0001863624","owner_name":"Cittadine Andrew","owner_display_name":"Cittadine Andrew","owner_url":"/insider/0001863624","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":12000.0,"shares_display":"12,000","price_per_share":0.6369,"price_display":"0.64","price_state":"stated","total_value":7642.8,"total_display":"7,642.80","total_whole":"7,643","shares_owned_after":69624.0,"shares_owned_after_display":"69,624","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-29","filed_date":"2024-05-31","scope":"insider"},{"id":6363809,"accession":"0001863624-22-000001","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001863624-22-000001","line_url":"/filing/0001863624-22-000001#line-2","is_derivative":false,"issuer_cik":"0001645469","issuer_name":"Monopar Therapeutics","issuer_ticker":"MNPR","issuer_name_source":null,"issuer_url":"/issuer/0001645469","owner_cik":"0001863624","owner_name":"Cittadine Andrew","owner_display_name":"Cittadine Andrew","owner_url":"/insider/0001863624","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":3.15,"price_display":"3.15","price_state":"stated","total_value":31500.0,"total_display":"31,500.00","total_whole":"31,500","shares_owned_after":24238.0,"shares_owned_after_display":"24,238","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-15","filed_date":"2022-11-16","scope":"insider"},{"id":6363808,"accession":"0001863624-22-000001","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001863624-22-000001","line_url":"/filing/0001863624-22-000001#line-1","is_derivative":false,"issuer_cik":"0001645469","issuer_name":"Monopar Therapeutics","issuer_ticker":"MNPR","issuer_name_source":null,"issuer_url":"/issuer/0001645469","owner_cik":"0001863624","owner_name":"Cittadine Andrew","owner_display_name":"Cittadine Andrew","owner_url":"/insider/0001863624","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6053.0,"shares_display":"6,053","price_per_share":3.0,"price_display":"3.00","price_state":"stated","total_value":18159.0,"total_display":"18,159.00","total_whole":"18,159","shares_owned_after":14238.0,"shares_owned_after_display":"14,238","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-14","filed_date":"2022-11-16","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":12,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":12,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":12},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001645469","name":"Monopar Therapeutics","url":"/issuer/0001645469","role":"Officer (Chief Operating Officer)","n_filings":5,"first_seen":"2022-11-16","last_seen":"2024-06-21"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001863624","retrieved_at":"2026-08-24T19:14:50+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}